Yeung‐Chul Mun

3.8k total citations
149 papers, 1.8k citations indexed

About

Yeung‐Chul Mun is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Yeung‐Chul Mun has authored 149 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Hematology, 50 papers in Oncology and 47 papers in Genetics. Recurrent topics in Yeung‐Chul Mun's work include Acute Myeloid Leukemia Research (33 papers), Multiple Myeloma Research and Treatments (28 papers) and Chronic Myeloid Leukemia Treatments (26 papers). Yeung‐Chul Mun is often cited by papers focused on Acute Myeloid Leukemia Research (33 papers), Multiple Myeloma Research and Treatments (28 papers) and Chronic Myeloid Leukemia Treatments (26 papers). Yeung‐Chul Mun collaborates with scholars based in South Korea, United States and Canada. Yeung‐Chul Mun's co-authors include Chu‐Myong Seong, Jin Seok Kim, Malcolm M. Bilimoria, Douglas B. Evans, Peter W. T. Pisters, J E Lee, Janice N. Cormier, Cheolwon Suh, Seok Jin Kim and Won Seog Kim and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Yeung‐Chul Mun

135 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yeung‐Chul Mun South Korea 22 647 634 455 422 344 149 1.8k
J. Mark Sloan United States 27 529 0.8× 510 0.8× 221 0.5× 1.0k 2.4× 387 1.1× 143 2.4k
Sung Hwa Bae South Korea 19 468 0.7× 382 0.6× 291 0.6× 274 0.6× 168 0.5× 101 1.2k
Sameena Iqbal United Kingdom 24 572 0.9× 270 0.4× 618 1.4× 337 0.8× 220 0.6× 65 2.0k
Lotta Hansson Sweden 27 550 0.9× 397 0.6× 255 0.6× 480 1.1× 160 0.5× 81 2.1k
Rika Sakai Japan 24 526 0.8× 465 0.7× 581 1.3× 129 0.3× 129 0.4× 107 1.5k
Frédéric Maloisel France 29 877 1.4× 1.6k 2.4× 484 1.1× 848 2.0× 234 0.7× 74 2.8k
David Sutton Canada 25 424 0.7× 884 1.4× 477 1.0× 269 0.6× 166 0.5× 57 2.2k
Zora Marjanovic France 22 378 0.6× 475 0.7× 907 2.0× 216 0.5× 270 0.8× 79 2.3k
Enrico Pogliani Italy 25 515 0.8× 1.7k 2.7× 412 0.9× 431 1.0× 185 0.5× 75 2.9k
Senji Kasahara Japan 21 434 0.7× 236 0.4× 425 0.9× 171 0.4× 119 0.3× 85 1.3k

Countries citing papers authored by Yeung‐Chul Mun

Since Specialization
Citations

This map shows the geographic impact of Yeung‐Chul Mun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yeung‐Chul Mun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yeung‐Chul Mun more than expected).

Fields of papers citing papers by Yeung‐Chul Mun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yeung‐Chul Mun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yeung‐Chul Mun. The network helps show where Yeung‐Chul Mun may publish in the future.

Co-authorship network of co-authors of Yeung‐Chul Mun

This figure shows the co-authorship network connecting the top 25 collaborators of Yeung‐Chul Mun. A scholar is included among the top collaborators of Yeung‐Chul Mun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yeung‐Chul Mun. Yeung‐Chul Mun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jong Wook, Jun Ho Jang, Shigeru Chiba, et al.. (2025). Romiplostim with ciclosporin A in patients with aplastic anaemia naïve to immunosuppressive therapy: A phase 2/3 study. British Journal of Haematology. 207(2). 582–590.
2.
3.
Kim, Jin Seok, Jun Ho Jang, Deog‐Yeon Jo, et al.. (2023). Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea. Journal of Korean Medical Science. 38(41). e328–e328. 3 indexed citations
4.
Jung, Eun Hee, Junshik Hong, Sung‐Yong Kim, et al.. (2022). Real-World Outcomes of Ruxolitinib in Patients With Myelofibrosis Focusing on Red Blood Cell Transfusion: A Multicenter Study From the MPN Working Party of the Korean Society of Hematology. Clinical Lymphoma Myeloma & Leukemia. 22(10). e931–e937. 1 indexed citations
5.
Jung, Sung‐Hoon, Kihyun Kım, Jae Hoon Lee, et al.. (2022). Relapse with plasmacytoma after upfront autologous stem cell transplantation in multiple myeloma. Annals of Hematology. 101(6). 1217–1226. 2 indexed citations
6.
Kim, Yi‐Jun, Hee Jin Huh, Hae‐Sun Chung, et al.. (2021). Comprehensive DNA repair gene expression analysis and its prognostic significance in acute myeloid leukemia. Hematology. 26(1). 904–913. 3 indexed citations
7.
Jo, Jae‐Cheol, Yoo Jin Lee, Sang Eun Yoon, et al.. (2021). Development of a new risk stratification system for patients with newly diagnosed multiple myeloma using R-ISS and 18F-FDG PET/CT. Blood Cancer Journal. 11(12). 190–190. 14 indexed citations
8.
Jung, Sung‐Hoon, Young Rok, Dae Sik Kim, et al.. (2020). Reduced-Intensity Conditioning with Busulfan and Fludarabine for Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia. Yonsei Medical Journal. 61(6). 452–452.
9.
10.
Jeong, Tae‐Dong, et al.. (2019). Somatic mutation of HLA‐DRB1*04:03 in a patient with myelodysplastic syndrome at diagnosis. HLA. 93(4). 216–219. 2 indexed citations
11.
Hong, Junshik, Soo‐Mee Bang, Yeung‐Chul Mun, et al.. (2018). Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP). Journal of Korean Medical Science. 33(19). e142–e142. 8 indexed citations
12.
Lee, Won-Sik, Hyeoung‐Joon Kim, Jee Hyun Kong, et al.. (2017). Very Early Molecular Response at 1 Month Is a Predictor of the Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors. Blood. 130. 1593–1593. 1 indexed citations
13.
Choi, Jung Hye, Tae Min Kim, Hyo Jung Kim, et al.. (2017). Multicenter Retrospective Analysis of Clinical Characteristics, Treatment Patterns, and Outcomes in Very Elderly Patients with Diffuse Large B-Cell Lymphoma: The Korean Cancer Study Group LY16-01. Cancer Research and Treatment. 50(2). 590–598. 7 indexed citations
14.
Huh, Hee Jin, Yeung‐Chul Mun, Chu‐Myong Seong, et al.. (2015). Calreticulin mRNA expression and clinicopathological characteristics in acute myeloid leukemia. Cancer Genetics. 208(12). 630–635. 5 indexed citations
15.
16.
Kım, Kihyun, Dok Hyun Yoon, Jin Seok Kim, et al.. (2014). Clinical Factors Associated with Response or Survival after Chemotherapy in Patients with Waldenström Macroglobulinemia in Korea. BioMed Research International. 2014. 1–7. 3 indexed citations
17.
Kım, Kihyun, Mark Lee, Hyo Jung Kim, et al.. (2013). Observational Study Of VMP (Bortezomib, melphalan, prednisolone) Regimen For Newly Diagnosed Korean Myeloma Patients Who Are Not Eligible For Transplantation. Blood. 122(21). 5379–5379. 3 indexed citations
18.
Lee, Young Ho, et al.. (2013). A proposal for improvement in the utilization rate of banked cord blood. Blood Research. 48(1). 5–5. 7 indexed citations
19.
Suh, Cheolwon, Daniel Lee, Chang‐Ki Min, et al.. (2010). Immunoglobulin D multiple myeloma: response to therapy, survival, and prognostic factors in 75 patients. Annals of Oncology. 22(2). 411–416. 25 indexed citations
20.
Woo, Chang-Hoon, Min‐Hyuk Yoo, Hye Jin You, et al.. (2003). Transepithelial Migration of Neutrophils in Response to Leukotriene B4 Is Mediated by a Reactive Oxygen Species-Extracellular Signal-Regulated Kinase-Linked Cascade. The Journal of Immunology. 170(12). 6273–6279. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. Mark Sloan Breakdown of academic impact, for papers by Sung Hwa Bae Breakdown of academic impact, for papers by Sameena Iqbal Breakdown of academic impact, for papers by Lotta Hansson Breakdown of academic impact, for papers by Rika Sakai Breakdown of academic impact, for papers by Frédéric Maloisel Breakdown of academic impact, for papers by David Sutton Breakdown of academic impact, for papers by Zora Marjanovic Breakdown of academic impact, for papers by Enrico Pogliani Breakdown of academic impact, for papers by Senji Kasahara
Rankless by CCL
2026